top of page
Action 24
Develop a toolkit to set standards and support accelerated research, development, and introduction of priority paediatric formulations.
Committed by:
Global Accelerator Partners
Sub-Actions & Milestones

Responsible

Updates

Notes

Sub-action 24.1

Develop a toolkit to set standards and support accelerated research, development, and introduction of priority paediatric formulations.

GAP-f

WHO and Unitaid in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group launched Toolkit for research and development of paediatric antiretroviral drugs and formulations available as PDF at http://www.who.int/hiv/pub/research-dev-toolkit-paediatric-arv-drug-formulation/en/ is also available as online tool at  https://globalhealthtrainingcentre.tghn.org/research-toolkit-paediatric-antiretroviral-drug-and-formulation-development/ . Following wide dissemination at AIDS 2018 and the Paediatric Workshop the toolkit is being further disseminated to industry and relevant stakeholder via a series of 6 webinars that will be completed by the end of the year (2 webinars already convened). Scientific papers for further dissemination are under development.

-

Milestone 24.1.1

Toolkit developed and launched at IAC.

-

-

-

Document (s)

-

-

-

-

bottom of page